A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Wesley Rehabilitation Center Specializes in Patients from Design to Care
Casa Colina Center for Disorders of Consciousness Officially Opens
Legionella Detected at Michigan Health Facility
Crystal Spring Tower Opens at Carilion Roanoke Memorial Hospital
Hospital Evacuation Highlights Importance of Emergency Preparedness